Subject Matter Expertise
HOPA takes pride in our members and their valuable contributions to the field of hematology/oncology pharmacy. See some of our member-experts in action below.
Women Pharmacists Day
(Oct 12, 2024) Recognizing the Role of Women in Improving Patient Care Access
In an interview with Pharmacy Times, Jolynn Sessions, PharmD, BCOP, FHOPA, clinical pharmacist and president of the Hematology Oncology Pharmacy Association (HOPA), shared her experience working in pharmacy. She also shared why it is important to recognize and support women in the pharmacy profession.
Watch the 6:21 video or visit Pharmacy Times to read the transcript.
Cultural Competency
(June 27, 2024) Having Conversations and Practicing Cultural Competency With LGBTQIA+ Patients
"If you go out there and Google 'cultural competency in health care,' you're going to see a lot of different definitions for it. But what it comes down to, at its core, it is being respectful and responsive for the patients' needs and beliefs," says Tad Autry, PharmD, in this Pharmacy Times interview.
Total run time is 13:32. You can also visit Pharmacy Times to read the transcript.
Women Pharmacist Day
(Oct 12, 2023) Mentorship in Oncology Pharmacy Has an Impact
HOPA President LeAnne Kennedy discusses the importance of mentorship in oncology pharmacy as well as the value of HOPA’s mentorship initiatives.
Pharmacy Times spoke to LeAnne as part of their celebration of Women Pharmacist Day.
Among other takeaways, in the interview LeAnne says, "One of the things that I love to do is to train other people. To see that light, when they get it—when you're explaining a clinical practice subject, and that lightbulb goes off—I think that's so exciting, then to see that as they get involved within HOPA."
Experts: The Hematology-Oncology Pharmacist Great Migration Is Caused by Issues Outside of Burnout That Could Be Quickly Addressed
Zahra Mahmoudjafari, PharmD, BCOP, DPLA; Alison Gulbis, PharmD, BCOP; and Kamakshi Rao, PharmD, BCOP, FASHP, discuss the underlying causes of the hematology-oncology pharmacist great migration from the field.
National Survey on the Effect of Oncology Drug Shortages in Clinical Practice: A Hematology Oncology Pharmacy Association Survey
Ali McBride , PharmD1,2; Sarah Hudson-DiSalle, PharmD3; Jeff Pilz , PharmD3; Mark Hamm, PharmD4; Brooke Boring, MPH5; Larry W. Buie, PharmD6; and David L. DeRemer , PharmD7,8
The purpose of this survey was to characterize the impact of oncology drug shortages across the United States, including the experiences of health care organizations, resource implications, and the impact on patient safety, patient care, and clinical trials.
HOPA Provides Plan to Address Oncology Drug Shortages
Experts discuss insight from a recently published oncology drug shortages research project and HOPA’s plan to address related issues based on the project’s findings.
Pharmacy Times interviewed Sarah Hudson-Disalle, PharmD, RPh, pharmacy manager in the Department of Pharmacy at the Ohio State Wexner Medical Center and chair of the Public Policy Committee at the Hematology/Oncology Pharmacy Association (HOPA), and Jeffrey Pilz, PharmD, MPA, MS, BCPS, assistant director of pharmacy – medication safety and drug policy in the Department of Pharmacy at the Ohio State Wexner Medical Center and vice chair of the Public Policy Committee at the HOPA, on HOPA’s oncology drug shortages research project.